Sorry. You can not access the page.

The page pro.biontech.com is not accessible from your location. You have been redirected to our corporate website for more information and resources.

Close

News & Media

Explore the latest news from BioNTech, including press releases, media updates, and further press material for download.

Financial news

05.05.2026

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

Read more
Download PDF

Latest News

Explore more

Media downloads
Logos

BioNTech logo

Official BioNTech logo representing the company’s global presence in cancer research, oncology innovation, and mRNA-based biotechnology.

PNG 19 KB
Download
Research and Development

Our scientists working in the lab

BioNTech scientists collaborating in a laboratory environment, supporting cancer research, oncology innovation, and development of mRNA-based immunotherapies.

JPG 224.22 KB
Download
Research and Development

Our scientists working in the lab

BioNTech scientist performing precise laboratory work using pipetting techniques to support cancer research and development of mRNA-based therapies.

JPG 249.53 KB
Download
Sites and buildings

Headquarter in Mainz

BioNTech headquarters in Mainz, Germany, supporting global cancer research, oncology innovation, and development of mRNA-based immunotherapies.

JPG 8.57 MB
Download
Research and Development

Our scientists working in the lab

BioNTech laboratory team reviewing research data and results to support cancer research and oncology-focused innovation.

JPG 226.53 KB
Download
Research and Development

Our scientists working in the lab

Team of BioNTech scientists working in laboratory settings to drive innovation in cancer research and mRNA-based immunotherapy development.

JPG 7.31 MB
Download
Research and Development

BioNTech gloves

Laboratory gloves used in BioNTech research environments to ensure safety and precision in cancer research and biotechnology workflows.

JPG 9.12 MB
Download

Annual report 2025

In 2025, BioNTech has gained momentum in executing its strategy and shaping the future of medicine. Building on the foundation laid in recent years, we have accelerated our evolution with the aim of becoming a multi-product company. Access our 2025 annual report for insights into achievements, pipeline updates and a summary of our financial results.

Download annual report

For healthcare professionals

Our innovative research and development programs are focused on delivering transformative treatments for patients with cancer. We are committed to working with healthcare professionals to improve patient outcomes.

To medical portal

For investors

We are dedicated to driving shareholder value through strategic investments in innovative oncology therapies. Our leadership is committed to transparency and delivering long-term growth.

To investors portal

Stay up to date

You want to receive the latest information about our company by e-mail? Sign up to our mailing list.

Sign up

Media Contact

Jasmina Alatovic

Senior Vice President Global Corporate Communications & External Affairs

 

media@biontech.de

BioNTech SE
An der Goldgrube 12
55131 Mainz, Germany

T: +49 6131 9084-0
F: +49 6131 9084-2121
M: service@biontech.de

© 2026 BioNTech SE. All rights reserved.

BNT